Global X Aging Population ETF Rating $33.41 +0.07 (+0.21%) Closing price 09/17/2025 03:56 PM EasternExtended Trading$33.43 +0.02 (+0.06%) As of 09/17/2025 04:10 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Ratings Stock AnalysisChartDividendHoldingsOptions ChainOwnershipRatingsShort InterestTrendsBuy This Stock Global X Aging Population ETF Aggregate Rating and Price Target (2025)How MarketBeat Aggregates ETF Rating and Price TargetMarketBeat calculates the aggregate rating and price target for an ETF by considering the weight of each stock in its portfolio. These ratings and price targets are based on the most recent ratings given by Wall Street analysts over the past year. The aggregate rating reviews the ETF's overall performance and is categorized as strong sell, sell, reduce, hold, moderate buy, buy, or strong buy. The aggegreate price target represents the average potential upside for the consensus price target of individual holdings in the ETF.AGNG Aggregate RatingModerate Buy 2.72Holdings in AGNG have an aggregate rating of Moderate Buy based on 305 analyst ratings issued in the past year covering 16 companies (44.0% of the portfolio).AGNG Aggregate Price Target$33.41High Prediction$33.41Average Prediction$33.41Low Prediction$33.41Holdings in AGNG have an aggregate price target of $33.41 and a range of $33.41 to $33.41 covering 16 companies (44.0% of the portfolio).AGNG Consensus Ratings of HoldingsStrong Buy0 Strong Buy rating(s)Buy2 Buy rating(s)Moderate Buy11 Moderate Buy rating(s)Hold3 Hold rating(s)Reduce0 Reduce rating(s)Sell0 Sell rating(s)Strong Sell0 Strong Sell rating(s) Ratings for Stocks Held by Global X Aging Population ETF Strong Sell Sell Reduce Hold Moderate Buy Buy Strong Buy Ratings for the Top 16 AGNG Holdings Export to ExcelWeight In ETFCompanyShare PriceMarketRank™Consensus Rating ScoreConsensus Price TargetPossible UpsideNumber of RatingsIndicator(s)ViewRatings3.21%AZNAstraZeneca$77.69+0.2%2.8114 of 5 stars2.75$86.00 10.7%4Positive NewsShort Interest ↑Analyst Revision3.17%WELLWelltower$165.89+0.4%4.6334 of 5 stars2.80$175.80 6.0%10Positive NewsAnalyst ForecastOptions Volume3.10%ABBVAbbVie$220.16+1.8%4.7354 of 5 stars2.93$222.68 1.1%27Trending NewsAnalyst ForecastAnalyst Revision3.02%JNJJohnson & Johnson$176.98+0.3%4.6949 of 5 stars2.62$177.87 0.5%21Trending NewsAnalyst Forecast3.01%EWEdwards Lifesciences$75.20+0.1%4.7756 of 5 stars2.70$87.17 15.9%23Positive NewsShort Interest ↑2.99%BSXBoston Scientific$98.52-0.5%4.8548 of 5 stars3.08$118.04 19.8%26Positive NewsOptions Volume2.92%SYKStryker$376.600.0%4.9523 of 5 stars2.78$431.42 14.6%18Positive News2.90%MDTMedtronic$94.57+0.4%4.9446 of 5 stars2.65$102.27 8.1%20Positive News2.74%MRKMerck & Co., Inc.$81.11+0.0%4.9993 of 5 stars2.33$106.41 31.2%21Trending NewsEx-DividendAnalyst Downgrade2.68%LLYEli Lilly and Company$760.39-0.6%4.9965 of 5 stars2.67$939.61 23.6%24Trending NewsAnalyst Forecast2.57%REGNRegeneron Pharmaceuticals$585.50+1.8%4.756 of 5 stars2.82$817.67 39.7%28Trending NewsShort Interest ↑2.56%AMGNAmgen$274.71+0.6%4.6564 of 5 stars2.24$304.43 10.8%21Positive News2.33%ONCBeOne Medicines$332.20+1.5%1.7148 of 5 stars3.00$330.89 -0.4%72.29%BMYBristol Myers Squibb$46.13-0.5%4.8977 of 5 stars2.24$56.38 22.2%21Positive NewsDividend AnnouncementAnalyst Revision2.28%VTRVentas$67.33-1.1%4.8199 of 5 stars2.92$75.27 11.8%12Positive NewsAnalyst Forecast2.24%DXCMDexCom$76.44-0.1%4.9762 of 5 stars2.91$99.89 30.7%22Positive News This page (NASDAQ:AGNG) was last updated on 9/18/2025 by MarketBeat.com Staff From Our PartnersREVEALED: Something Big Happening Behind White House Doorswhat I just learned about what’s unfolding in the White House is truly stunning… And you need to see it for...Paradigm Press | SponsoredGenerate up to $5,000/month with 10X less money?The secret to retiring without a million-dollar nest egg. I'm talking about generating enough monthly inco...Investors Alley | SponsoredTrump’s national nightmare is herePorter Stansberry and Jeff Brown say a new U.S. national emergency is already underway — and it could trigger ...Porter & Company | SponsoredWarren Buffett’s #1 AI Stock: Not Mag 7, And NOT on the NasdaqNew Amazon Crisis Could Tank U.S. Stock Market A new panic is halting AI projects at Amazon and could split...Altimetry | SponsoredCrypto Gets Official Government Backing—Here's the WinnerTrump Just Signed the GENIUS Act—One Coin is About to Explode We're at the BEGINNING of smart money really ...Crypto 101 Media | SponsoredCollege grad makes $64,000 a monthA Wall Street legend just helped train our own proprietary AI system in the stock market (a project that took ...Stansberry Research | SponsoredWhy More Investors Are Using Family Trusts to Protect Their WealthFor many investors, a family trust can be an essential tool for protecting assets, avoiding probate, and ensur...SmartAsset | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Global X Aging Population ETF Please log in to your account or sign up in order to add this asset to your watchlist. Share Global X Aging Population ETF With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
